Những podcast I3 hay nhất (2024)

1
Additional Advances in Rett Syndrome Research and Clinical Trials With Timothy John Feyma, MD 5:00

2d ago5:00

5:00

Dr. Timothy John Feyma, Pediatric Neurologist at Gillette Children’s Hospital, is currently serving as chair of i3 Health’s CME/NCPD activity, Exploring Novel Treatments for Rett Syndrome. With new developments in the field occurring over recent months, Dr. Feyma sat down with us again to share new updates in treatment and management of Rett syndro…

1
1919: Interview with i3 Energy CEO, Majid Shafiq 15:24

6d ago15:24

15:24

Watch on YouTube Following on from a recent sector report from Vox Markets, i3 Energy's #I3E Majid Shafiq joins us to take a deeper dive into the company's extensive ESG activities, as well as to talk about the wider market in North American natural gas and the company's outlook for the rest of the current year and on into 2025.…

1
101: ECP's Damon Callaghan and Sam Byrnes 47:22

23d ago47:22

47:22

In episode 101 of the [i3] Podcast, we speak with Damon Callaghan and Sam Byrnes of asset management firm ECP. ECP was established by Dr. Manny Pohl of Hyperion Asset Management fame and in this episode we talk about the opportunities and challenges of artificial intelligence when investing in Australian equities. Enjoy the show!01:00 How we got st…

1
1924: The Exchange with Paul Scott of Stockopedia 1:55:35

5h ago1:55:35

1:55:35

On today’s VOX Markets live, I was delighted again to speak to expert UK smallcap investor, analyst & commentator Paul Scott of Stockopedia.Bởi Vox Markets Podcast

1
Reimagining Surgery Through AI and Computer Vision Technology: Dr. Tamir Wolf and Dr. Waqas Haque 15:42

5h ago15:42

15:42

In this episode of Exploring Artificial Intelligence in Oncology, Dr. Waqas Haque sits down with Dr. Tamir Wolf, Co-Founder and CEO of Theator, a company pioneering next-generation AI and computer vision technology to automatically capture and analyze surgical data in real time to generate actionable insights and improve surgical outcomes.…

1
1923: Q&A with Eleco CEO Jonathan Hunter and CFO Neil Pritchard 20:01

7h ago20:01

20:01

In this interview, CEO Jonathan Hunter and CFO Neil Pritchard of Eleco kindly take me through: 1. What this leading Buildtech software developer does, its main USPs and the current health of the market. 2. Highlights from today's strong and in line H1’24 trading update. 3. New products recently launched 4. Integration of Vertical Digital and robust…

1
All in for AI 24:54

17h ago24:54

24:54

Learn from Hannah Kershaw, Chief Product Officer for Domestic and General Insurance.Bởi Insurance Industry Insights (I3)

1
Real Value, No Hype 38:00

1d ago38:00

38:00

Learn from Sandeep Karkhanis, Head of Machine Learning Strategy and Delivery at Allianz.Bởi Insurance Industry Insights (I3)

1
1921: Interview with Aiden Lavelle from European Green Transition 4:06

3d ago4:06

4:06

Encouraging results from European Green Transition's Limni copper project in Cyprus, where samples show useful-looking levels of copper and gold. Here to tell us what it means, and to talk about next steps, is EGT's Aiden Lavelle.Bởi Vox Markets Podcast

1
1922: The Exchange with Christopher & Nick Mills of Harwood Capital 1:18:49

3d ago1:18:49

1:18:49

Watch on YouTube In this investing masterclass, I was delighted again to speak to legendary UK small/midcap fund managers Christopher and Nicholas (Nick) Mills of harwoodcapital – including: 00:00 Investment approach, Nick’s background & fund performance 07:15 NIOX 11:05 Pinewood Technologies 14:35 EKFdiagnostics 16:50 Trifast 22:40 Carr's Group 26…

1
1921: Interview with Steve Kesler, Chairman of CleanTech Lithium 13:12

4d ago13:12

13:12

More encouraging results from CleanTech Lithium, as grades and recoveries continue from its DLE project in Chile to hold up well, real progress is being made with the pilot plant in Chicago, and conversations with potential off-take partners look well set up. As the company moves towards completion of a pre-feasibility study, Steve Kesler joins us …

1
1920: The Exchange Live: Roland Head & Paul Hill 1:13:06

6d ago1:13:06

1:13:06

Watch on YouTube On this morning’s Vox Markets Exchange, I was delighted again to speak to accomplished investor Roland Head of Stockopedia including: 00:00 His investment approach, YTD returns & the outlook for equities 08:00 Burberry 13:40 Duke Capital 15:40 Serica Energy 20:45 James Halstead 25:30 Renold 27:20 Page group 30:50 The Property Franc…

1
REAL VALUE, NO HYPE 38:00

8d ago38:00

38:00

Sandeep Karkhanis, Head of ML Strategy at Allianz covers real value creation from AI.Bởi Insurance Industry Insights (I3)

1
1918: Q&A with hVIVO’s Mo Khan 5:55

9d ago5:55

5:55

Vox Markets speaks with hVIVO #HVO CEO Yamin 'Mo' Khan about the company's record-breaking first half of 2024. Yamin details their impressive achievement of £35.6 million in revenue, marking a 31% increase from the previous year, and an EBITDA margin of 24%. He also highlights the successful operation of three facilities, including their new state-…

1
1917: Interview with Aiden Lavelle from European Green Transition 3:35

9d ago3:35

3:35

Watch on YouTube Some useful looking sample results from European Green Transition's Olserum rare earths project today. Aiden Lavelle joins us to talk about the implications, and the company's plans to get drilling in the near-termBởi Vox Markets Podcast

1
1916: Q&A with Gunsynd Executive Chairman, Hamish Harris 5:59

9d ago5:59

5:59

Gunsynd's Hamish Harris joins us to talk about the company's latest additions to its portfolio in the copper and uranium spaces, as well as to update on the latest from other assets the company owns and the exit from the Metals One farm-in.Bởi Vox Markets Podcast

1
1914: Interview with Metals One CEO, Jonathan Owen 14:19

9d ago14:19

14:19

More progress on the ground from Metals One in Finland, as the latest results from its Black Schist nickel project come in. The company's resource base has been considerably enhanced, and it is now moving to complete a preliminary economic assessment by the end of the year. Here, with all the details, is CEO Jonathan Owen…

1
1915: Q&A with Cobra Resources CEO, Rupert Verco 10:13

9d ago10:13

10:13

Cobra Resources has a rare earths project in Australia that looks likely to be of a high enough quality and cheap enough to operate to challenge the Chinese stranglehold on the market. What's more, the proposed method of production is in-situ leach, which means no actual earth moving will occur, and the environmental footprint will be corresponding…

1
1913: Q&A with Verici DX CEO, Sara Barrington 23:52

10d ago23:52

23:52

Watch on YouTube In this interview, CEO Sara Barrington of Verici DX – an advanced medical diagnostics firm focusing on the global kidney transplant market - takes me through today’s strong H1’24 results and multiple value catalysts ahead for the business. 00:00 Recap of #VRCI’s unique technology and USPs 05:30 Ground breaking licensing deal with T…

1
1912: The Exchange with Gervais Williams 50:10

10d ago50:10

50:10

With on YouTube On this morning’s Vox Markets live, I was delighted again to speak to legendary UK small/midcap fund manager Gervais Willaims of Premier Miton– including: 00:00 Investment approach & outlook for equities. 05:15 Yü Group PLC 07:30 Zephyr Energy 10:25 Supreme 12:35 Elecosoft 15:10 Inspiration Healthcare 18:40 Galliford Try 21:10 Lords…

1
1907: The Exchange with Michael Taylor 49:08

13d ago49:08

49:08

On this morning’s VOX markets live Exchange, I was delighted again to speak to influential stock trader Michael Taylor of Shifting Shares – including: 00:00 Investment approach & how his portfolio has fared. 03:50 Equals 07:40 PCIPAL 13:10 finseta 16:15 Avacta 19:20 Intercede My ID 23:55 WaterIntel PLC 26:00 Supreme PLC 28:20 Science in Sport 32:30…

1
1911: Q&A with EARNZ Executive Chairman, Bob Holt, OBE 12:48

16d ago12:48

12:48

Bob Holt, Chairman of EARNZ plc provides insights into his professional journey, elaborates on the company's vision, discusses industry trends, and highlights EARNZ's innovative strategies.Bởi Vox Markets Podcast

1
1910: Vox Markets Fund Manager Series: Sid Lall, manager of the Marlborough Multi Cap Income 47:58

16d ago47:58

47:58

Watch on YouTube In this investing masterclass, I was delighted again to speak to accomplished fund manager Sid Lall of Canaccord – including: 00:00 His investment approach, thoughts on the markets & how the Marlborough Multi Cap Income fund has fared. 07:10 Sectors which may benefit from Labour’s election win. 08:35 Morgan Sindall 12:55 Hargreaves…

1
1909: Interview with CEO James Hickman of Finseta 12:25

17d ago12:25

12:25

Watch on YouTube In this interview, CEO James Hickman of Finseta #FIN – an international payments platform - takes me through the business’ strong H1’24 trading, increasing profit margins, outlook for the rest of 2024 and longer term expansion strategy.Bởi Vox Markets Podcast

1
Practice-Changing Advances in the Management of Hemophilia 42:37

17d ago42:37

42:37

In this podcast, hear expert perspectives on practice-changing advances in the treatment and personalized management of patients with hemophilia from Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology/Oncology, and Professor of Pediatrics at Keck School of Medicine of USC; and Dr. Jennifer Davila, Co…

1
Investigating Axicabtagene Ciloleucel for R/R Central Nervous System Lymphoma: Lakshmi Nayak, MD 11:30

18d ago11:30

11:30

Investigating Axicabtagene Ciloleucel for R/R Central Nervous System Lymphoma: Lakshmi Nayak, MD by i3 HealthBởi i3 Health

1
1907: Interview with joint CEO Matt Timmins of Fintel 17:31

20d ago17:31

17:31

In this upbeat interview, joint CEO Matt Timmins of Fintel takes me through the strategic rationale behind this week's £14.6m acquisition of threesixty, how the deal fits into the wider group, and where the business hopes to be in 5 years' time.Bởi Vox Markets Podcast

1
1907: The Exchange with Iain Staples 1:00:38

20d ago1:00:38

1:00:38

On this morning’s Exchange, I was delighted again to speak to accomplished investor & ex fund manager Iain Staples – including: 00:00 Investment approach & how his portfolio has fared. 03:55 @equals__money 08:25 @Chemring_Group, Cohort & defence 12:10 @DiageoGB 15:30 @CMCMarkets 18:50 @FundingCircleUK 22:05 IG Design Group 26:35 @SandersnDesign 29:…

1
1907: Interview with IntelliAM AI - “It's a multibillion-pound industry that we're focusing on” 14:42

23d ago14:42

14:42

Vox Markets speaks to Tom Clayton and Daud Khan, CEO and CFO of newly Aquis floated IntelliAM AI, about the huge opportunity delivering innovative machine learning solutions for the FMCG manufacturing industry. In this interview, Vox Markets speaks with Tom Clayton and Daud Khan, respectively CEO and CFO of newly Aquis-listed IntelliAM AI, which de…

1
1907: Q&A with fund manager Richard Staveley of Harwood Capital 1:02:58

23d ago1:02:58

1:02:58

In this masterclass of smallcap investing, I was delighted again to speak to accomplished fund manager Richard Staveley of Harwood Capital – including: 00:00 His investment approach & how the Rockwood Strategic portfolio has fared. 03:51 Capita 10:22 Filtronic 17:32 Trifast 23:01 Pressure Technologies 29:46 RM 36:28 Funding Circle 42:13 Argentex 50…

1
1908: Q&A with Supreme CEO Sandy Chadha & CFO Suzanne Smith 12:39

24d ago12:39

12:39

Watch on YouTube In this interview, CEO Sandy Chadha and CFO Suzanne Smith of Supreme take me through today's record March FY24 results, positive start to the new year and attractive long term vision for the group.Bởi Vox Markets Podcast

1
Insurance Industry Insights - All in for AI 24:54

24d ago24:54

24:54

Learn how Domestic and General Insurance is reimagining use cases and innovating new products and services through the precision use of AI and Machine Learning.Bởi Insurance Industry Insights (I3)

1
Combating Health Disparities Through More Equitable Screening: Chyke Doubeni, MD, MPH 6:16

28d ago6:16

6:16

Combating Health Disparities Through More Equitable Screening: Chyke Doubeni, MD, MPH by i3 HealthBởi i3 Health

1
Multicancer Early Detection - What's Your Opinion? with Chyke Doubeni, MD, MPH 6:45

28d ago6:45

6:45

Multicancer Early Detection - What's Your Opinion? with Chyke Doubeni, MD, MPH by i3 HealthBởi i3 Health

1
The Latest Data on Zanidatamab for HER2-Positive Biliary Tract Cancer: Shubham Pant, MD 4:07

28d ago4:07

4:07

The Latest Data on Zanidatamab for HER2-Positive Biliary Tract Cancer: Shubham Pant, MD by i3 HealthBởi i3 Health

1
Biomarker Documentation in the Community Setting and Clinical Decision Support: Daniel Rubin, PharmD 8:25

28d ago8:25

8:25

Biomarker Documentation in the Community Setting and Clinical Decision Support: Daniel Rubin, PharmD by i3 HealthBởi i3 Health

1
Community Oncology Pharmacists - Their Crucial Role and Clinical Impact: Andrea Roman, PharmD, BCOP 7:37

28d ago7:37

7:37

Community Oncology Pharmacists - Their Crucial Role and Clinical Impact: Andrea Roman, PharmD, BCOP by i3 HealthBởi i3 Health

1
Cancer and Careers - Empowering People with Cancer to Thrive in the Workplace: Rebecca Nellis, MPP 11:15

28d ago11:15

11:15

Cancer and Careers - Empowering People with Cancer to Thrive in the Workplace: Rebecca Nellis, MPP by i3 HealthBởi i3 Health

1
Exploring Association of FGFR3 Alterations in Urothelial Cancer: Arlene Siefker-Radtke, MD 9:29

28d ago9:29

9:29

Exploring Association of FGFR3 Alterations in Urothelial Cancer: Arlene Siefker-Radtke, MD by i3 HealthBởi i3 Health

1
Representing Symptom Research and Nursing at ASCO: Natalie Jackson-Carroll, PhD, APRN, FNP-C 7:35

28d ago7:35

7:35

Representing Symptom Research and Nursing at ASCO: Natalie Jackson-Carroll, PhD, APRN, FNP-C by i3 HealthBởi i3 Health

1
Worth the Wait - Supporting Young Adult Cancer Survivors on the Path to Parenthood: Mike Scherer 8:19

28d ago8:19

8:19

Worth the Wait - Supporting Young Adult Cancer Survivors on the Path to Parenthood: Mike Scherer by i3 HealthBởi i3 Health

1
Optimizing Sacituzumab Govitecan Tolerability in TNBC With Early Management: Antonio Llombart, MD 7:09

28d ago7:09

7:09

Optimizing Sacituzumab Govitecan Tolerability in TNBC With Early Management: Antonio Llombart, MD by i3 HealthBởi i3 Health

1
Understanding Lung Cancer Diagnostic Trends to Inform Therapeutic Development: Jess Paulus, SCd 10:29

28d ago10:29

10:29

Understanding Lung Cancer Diagnostic Trends to Inform Therapeutic Development: Jess Paulus, SCd by i3 HealthBởi i3 Health

1
Intuitively Designing Clinical Trials to Empower Patients: Ishwaria Subbiah, MD 20:22

28d ago20:22

20:22

Intuitively Designing Clinical Trials to Empower Patients: Ishwaria Subbiah, MD by i3 HealthBởi i3 Health

1
Updated Results from the SPOTLIGHT and EV-302 Trials at ASCO: Ahsan Arozullah, MD, MPH 7:58

28d ago7:58

7:58

Updated Results from the SPOTLIGHT and EV-302 Trials at ASCO: Ahsan Arozullah, MD, MPH by i3 HealthBởi i3 Health

1
Improving Long-Term Survivorship Care in Head and Neck Cancer With Erica Fortune, PhD 11:56

28d ago11:56

11:56

At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down with Erica Fortune, PhD, Vice President of Research at Cancer Support Community, to discuss her team’s poster entitled, “Head and Neck Cancer (HNC) Survivors: Long-Term Nutrition Impact Symptoms, Eating Problems, and Barriers to Care I…

1
1907: Interview with Dr Zac Phillips of OAK Securities 5:56

29d ago5:56

5:56

OAK Securities has set a price target of 93p for shares in Helix Exploration, based in large part on the accretive value of the new helium acquisition, Rudyard. We spoke to Oak's Dr Zac Phillips about why he set a valuation on Rudyard of US$85m, about what the opportunities in helium in general are, and about the key value drivers that investors sh…

1
Addressing Barriers to Transplantation Accessibility With Monzr Al Malki, MD, and Richa Thakur, MD 11:47

29d ago11:47

11:47

At the conclusion of this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, Monzr Al Malki, MD, an Associate Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope, sat down with Richa Thakur, a Palliative Care Physician and Hematology/Oncology Fellow at Zucker School of Medicine at Hofstr…

1
Qure.ai: Improving Early Lung Cancer Detection Through AI with Ranjana Devi and Waqas Haque, MD, MPH 12:21

1M ago12:21

12:21

This installment of Oncology Data Advisor's Exploring Artificial Intelligence (AI) in Oncology series features a discussion recorded live at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting between Ranjana Devi, Vice President of Product Development, Oncology, at Qure.ai, and Fellows Forum member Dr. Waqas Haque. Check out the e…

Podcast đáng để nghe

Podcast I3

Podcast đáng để nghe

Hướng dẫn sử dụng nhanh